Lv11
6 积分 2023-12-27 加入
Defining immune reset: achieving sustained remission in autoimmune diseases
1小时前
已完结
The race to reset autoimmune diseases
2小时前
已完结
Targeting GPRC5D in multiple myeloma
3天前
已完结
CAR T-cell therapy in autoimmune diseases
4天前
已完结
CAR T-cells in autoimmunity: game changer or stepping stone?
4天前
已完结
Opportunities and limitations of B cell depletion approaches in SLE
7天前
已完结
One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn’s-like inflammatory bowel disease
7天前
已完结
Myostatin expression in lung cancer induces sarcopenia and promotes cancer progression
7天前
已完结
POS1160 A PHASE IB, MULTICENTRE, OPEN-LABEL, DOSE-ESCALATION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS AND PHARMACODYNAMICS OF SUBCUTANEOUSLY ADMINISTERED MOSUNETUZUMAB IN PARTICIPANTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
9天前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
24天前
已完结
皖公网安备34019202002308
